Suzhou Modif Biotechnology Co., Ltd.

Founded in 2021, Motif Biotech is located in Suzhou High-tech Zone. In March 2023, the peptide R&D and production base was completed and put into production. Motif Biotech is an innovative peptide CRDMO enterprise focusing on the customization, R&D, production and service of peptide-related products. Motif Biotech is committed to becoming an international platform integrating peptide scientific research and customization, drug peptide intermediates and impurity customization, peptide API production, drug peptide R&D and process development, and beauty peptide R&D and production. The factory building of Suzhou headquarters is about 4,300 square meters, with multiple R&D and production workshops, more than 100 synthesis/purification/analysis laboratories, and a planned total annual raw material production capacity of 30 kg (powder). The GMP workshop was designed and constructed according to ich Q7, and obtained the Pharmaceutical Manufacturing License in October 2024. The production and quality meet the requirements of FDA, EMA, and NMPA. The telpopeptide API was successfully registered with the FDA in January 2025 (DMF filing). With a complex long-acting peptide modification and optimization service platform, it can produce more than 95% of customized synthetic peptide types on the market; provide full-process peptide CDMO/CMC services from drug screening (SAR), preclinical CMC, clinical samples to registration support, as well as CRO, CMO, and beauty peptide one-stop services. We have accumulated more than 35 years of industry cooperation experience, more than 1,000 cooperative customers, and 2 production bases.

Suzhou Modif Biotechnology Co., Ltd. is located at Gongyeyuan District, Suzhou, Jiangsu Province, China.

Main peptides produced: Tirzepatide, Semaglutide, BPC-157, GHK-Cu, TB-500 (Thymosin Beta-4).

Website: https://cn.motifbiotech.com